arrow
A

Andrew H. Ahn

Sackler Faculty of Medicine
H指数:24
被引数:4,106

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Long-term real-world effectiveness and safety of fremanezumab in 1140 patients with migraine and at least 6 months of treatment: third interim analysis of the pan-European PEARL study

fremanezumab在1140名偏头痛患者中的长期真实世界有效性与安全性(至少6个月治疗):欧洲泛欧PEARL研究的第三次中期分析

2025-10-010
OA
Real-world effectiveness of fremanezumab for the preventive treatment of migraine: Interim analysis of the pan-European, prospective, observational, phase 4 PEARL study
2023-11-213
OA
Dose selection for fremanezumab (AJOVY) phase 3 pediatric migraine studies using pharmacokinetic data from a pediatric phase 1 study and a population pharmacokinetic modeling and simulation approach
2021-05-177
PREAI
Discovery and validation of biomarkers to aid the development of safe and effective pain therapeutics: challenges and opportunities

生物标志物的发现和验证,以帮助开发安全有效的疼痛疗法: 挑战和机遇

2020-06-15246
OAAI
Fremanezumab versus placebo for migraine prevention in patients with documented failure to up to four migraine preventive medication classes (FOCUS): a randomised, double-blind, placebo-controlled, phase 3b trial

Fremanezumab与安慰剂在记录的多达四次偏头痛预防药物课程失败的患者中预防偏头痛 (FOCUS): 一项随机,双盲,安慰剂对照,3b期试验

LANCET
IF88.5
2019-09-01259
PREAI